Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 20/20 | 0.85 |
| ▸ | DRD3 | P35462 | 20/20 | 0.85 |
| ▸ | HTR1D | P28221 | 1/20 | 0.54 |
| ▸ | HTR1B | P28222 | 1/20 | 0.54 |
| ▸ | DRD1 | P21728 | 1/20 | 0.54 |
| ▸ | DRD4 | P21917 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6974331 | 0.92 | DRD2 (0.88) | DRD2DRD3DRD1DRD4 | |
| SCHEMBL6975955 | 0.92 | DRD2 (1.00) | DRD2DRD3DRD1DRD4 | |
| SCHEMBL6976245 | 0.92 | DRD2 (1.00) | DRD2DRD3DRD1DRD4 | |
| SCHEMBL7976699 | 0.89 | DRD2 (0.93) | DRD2DRD3DRD1DRD4 | |
| SCHEMBL6975224 | 0.89 | DRD2 (0.84) | DRD2DRD3DRD1DRD4 | |
| SCHEMBL6976006 | 0.88 | DRD3 (0.82) | DRD2DRD3DRD1DRD4 | |
| SCHEMBL6981017 | 0.87 | DRD2 (0.84) | DRD2DRD3DRD1DRD4 | |
| SCHEMBL6980906 | 0.87 | DRD2 (1.00) | DRD2DRD3DRD1DRD4 | |
| SCHEMBL6975930 | 0.87 | DRD2 (1.00) | DRD2DRD3DRD1DRD4 | |
| SCHEMBL6982260 | 0.86 | DRD2 (0.86) | DRD2DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0917530-B1 | TETRAHYDROISOQUINOLINE DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS | SMITHKLINE BEECHAM PLC (GB) | 2003-02-19 | — | — | EP | claimed |
| US-6046210-A | ANTIPSYCHOTIC AGENTS | SMITHKLINE BEECHAM P.L.C. (GB) | 2000-04-04 | — | — | US | claimed |
| EP-0917530-B1 | TETRAHYDROISOQUINOLINE DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS | SMITHKLINE BEECHAM PLC (GB) | 2003-02-19 | — | — | EP | disclosed |
| US-6046210-A | ANTIPSYCHOTIC AGENTS | SMITHKLINE BEECHAM P.L.C. (GB) | 2000-04-04 | — | — | US | disclosed |